Multi-omics analysis of multiple myeloma patients with differential response to first line treatment
09.10.2023
The genome backgrounds of multiple myeloma (MM) would affect the efficacy of specific treatment. However, the mutational and transcriptional...
Sphenoid bone localization in the setting of highly aggressive and refractory Multiple Myeloma: A case report
09.10.2023
Multiple Myeloma (MM) is the most common primary osseous malignancy in adults, and it mainly affects men aged between 50 and 70 years. Although rare...
How should multiple myeloma research change in a patient oriented world? Findings and lessons from the pan Canadian…
09.10.2023
Abstract Background Over the last decade there has been considerable research into the treatment, management, and quality of life of people living...
Real World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory…
09.10.2023
Abstract Background Most patients with multiple myeloma (MM) relapse or become refractory, resulting in high health care costs. However, real world...
Risk of cancer specific death among octogenarians with multiple myeloma: A population based analysis
09.10.2023
Multiple myeloma (MM) is a hematologic malignancy characterized by the clonal proliferation of plasma cells in the bone marrow with a median age at...
The leucine rich 2 glycoprotein 1 levels in patients with multiple myeloma Study
09.10.2023
Abstract Introduction Angiogenesis is considered important in the pathogenesis of multiple myeloma (MM), as well as in the targeted treatment of the...
Validation of a Diagnostic Model to Differentiate Multiple Myeloma from Bone Metastasis
09.10.2023
Abstract Purpose A diagnostic model to differentiate multiple myeloma (MM) from bone metastasis (BM) in patients with destructive bone lesions (MM BM...